FDA approves drug for inflammatory disease

March 6, 2008

The U.S. Food and Drug Administration approved the drug rilonacept to treat a group of rare diseases causing rash, fever, chills and joint pain.

Rilonacept, marketed under the name Arcalyst by Regeneron Pharmaceuticals, received marketing approval for the treatment of Cyropyrin-Associated Periodic Syndromes, including Familial Cold Auto-inflammatory Syndrome and Muckle-Wells Syndrome in adults and children ages 12 and older.

The familial cold syndrome is an "orphan" hereditary disease affecting only about 300 people in the United States, 90 percent of whom can trace their ancestry to a single person who came to America in the 1600s, the University of California's San Diego School of Medicine said Wednesday in a news release. Symptoms can be triggered at any time by exposure to cold temperatures, stress or exercise,

The drug is based on a discovery by Dr. Hal Hoffman, a professor at the medical school, who identified the genetic basis of the disease as a mutation that causes alterations in the protein cryopyrin.

Copyright 2008 by United Press International

Explore further: Undermining host-cell defences

Related Stories

Undermining host-cell defences

August 15, 2016

Ludwig Maximilian University researchers have discovered that a protein which is well known for its role as a tumor suppressor is also required for inhibition of the replication of the coronavirus that causes SARS.

Researchers 'solve' key Zika virus protein structure

July 25, 2016

Researchers have revealed the molecular structure of a protein produced by the Zika virus that is thought to be involved in the virus's reproduction and its interaction with a host's immune system.

Rare Stevens-Johnson syndrome can be unpredictable, deadly

April 7, 2010

For Cody Strickland, it began with poison ivy. In his 21 years, the outdoorsy electrician was no stranger to the rash, which caught him for the last time in early February, at a bonfire party on the shores of Lake Pat Cleburne. ...

New treatment offers hope for short-bowel syndrome patients

July 18, 2013

A new drug, teduglutide, offers significant relief for patients with short-bowel syndrome intestinal failure who are reliant on intravenous nutrition, according to a new study in Clinical Gastroenterology and Hepatology, ...

Recommended for you

How the finch changes its tune

August 3, 2015

Like top musicians, songbirds train from a young age to weed out errors and trim variability from their songs, ultimately becoming consistent and reliable performers. But as with human musicians, even the best are not machines. ...

Cow embryos reveal new type of chromosome chimera

May 27, 2016

I've often wondered what happens between the time an egg is fertilized and the time the ball of cells that it becomes nestles into the uterine lining. It's a period that we know very little about, a black box of developmental ...

Shaving time to test antidotes for nerve agents

February 29, 2016

Imagine you wanted to know how much energy it took to bike up a mountain, but couldn't finish the ride to the peak yourself. So, to get the total energy required, you and a team of friends strap energy meters to your bikes ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.